Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on “The Close” that cancer testing accounts for about $1 billion of the company’s $11 billion portfolio.

Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on &ldquo;The Close&rdquo; that cancer testing accounts for about $1 billion of the company&rsquo;s $11 billion portfolio.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Quest Diagnostics CEO Jim Davis Talks Outlook

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/43fa43d7-3757-46e7-997d-b3ed017b1a37/transcript

Just three weeks into the job, Federal Reserve Chairman Kevin Warsh is already facing an unusually high-stakes test. We look ahead to this week's FOMC decision with Rebecca Patterson, Senior Fellow at the Council on Foreign Relations & former Chief Investment Strategist at Bridgewater Associates.

Just three weeks into the job, Federal Reserve Chairman Kevin Warsh is already facing an unusually high-stakes test.&nbsp;We look ahead to this week's FOMC decision with Rebecca Patterson, Senior Fellow at the Council on Foreign Relations &amp; former Chief Investment Strategist at Bridgewater Associates.

 Rebecca Patterson Talks Warsh, FOMC Preview

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/391ec9cc-b4fc-422f-a089-b46a01024b07/transcript

Gary Gensler, former Chair of the Securities and Exchange Commission, says SpaceX’s blockbuster IPO is part of a new era of mega-IPOs, raising questions about valuation, governance and what future AI debuts could look like. He also warns AI models could create a financial stability event and discusses the regulatory fight over prediction markets. He speaks with host Kailey Leinz.

Gary Gensler, former Chair of the Securities and Exchange Commission, says SpaceX&rsquo;s blockbuster IPO is part of a new era of mega-IPOs, raising questions about valuation, governance and what future AI debuts could look like. He also warns AI models could create a financial stability event and discusses the regulatory fight over prediction markets. He speaks with host Kailey Leinz.

Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cc4fa988-3ae7-43de-844f-b46701682ed3/transcript

Veteran short seller James Chanos says the SpaceX mega IPO is a troubling sign for the broader markets. He says "we're going to shatter" records this year when it comes to IPOs. He speaks to Tom Keene and Scarlet Fu on "Bloomberg Money."

Veteran short seller James Chanos says the SpaceX mega IPO is a troubling sign for the broader markets. He says "we're going to shatter" records this year when it comes to IPOs. He speaks to Tom Keene and Scarlet Fu on "Bloomberg Money."

Jim Chanos Talks SpaceX IPO

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/649bd946-aaba-476e-9681-b46701255218/transcript

Quest Diagnostics CEO Jim Davis Talks Outlook

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips